These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2368755)

  • 1. Waste of i.v. admixtures in the ADD-Vantage system and a traditional minibag system.
    Billeter M; Nowak MM; Rapp RP; Hunt ML
    Am J Hosp Pharm; 1990 Jul; 47(7):1598-600. PubMed ID: 2368755
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inexpensive microcomputer for intravenous admixture service applications.
    Lang JR
    Am J Hosp Pharm; 1983 Mar; 40(3):406-8. PubMed ID: 6846347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of seven methods of preparing and administering small-volume injections.
    Smith CF; Amen RJ
    Am J Hosp Pharm; 1988 Sep; 45(9):1896-901. PubMed ID: 3228122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring waste in an intravenous admixture program.
    Mitchell SR
    Am J Hosp Pharm; 1987 Jan; 44(1):106-11. PubMed ID: 3826083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for reducing i.v. drug waste and coping with increased workload.
    Hoolihan RJ; Erickson BA
    Hosp Pharm; 1987 Sep; 22(9):871-6. PubMed ID: 10312222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringes versus minibags as an intravenous admixture system: a comparison of cost and nursing preference.
    Gin A; Martens D; Dobson K; Hall K
    Can J Hosp Pharm; 1987 Jun; 40(3):81-5. PubMed ID: 10282581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing waste: a significant cost containment measure in an i.v. additive program.
    Coppola PA; Cassidy AP
    Hosp Pharm; 1987 Dec; 22(12):1215-6, 1246. PubMed ID: 10285376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous recording system for I.V. admixtures.
    Finch ME
    Am J Hosp Pharm; 1981 Nov; 38(11):1672, 1674. PubMed ID: 7304617
    [No Abstract]   [Full Text] [Related]  

  • 11. Justification of a pharmacy intravenous admixture service in an Australian hospital.
    Plumridge RJ; Maher M
    Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of product waste in i.v. admixture programs.
    Vogel DP; Eck TA; Witte KW
    Am J Hosp Pharm; 1986 Apr; 43(4):952-3. PubMed ID: 3706344
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing i.v. waste to under 2.25 percent.
    Newhouse JG; Paul VM; Waugh NA; Frye CB
    Hosp Pharm; 1988 Mar; 23(3):241-2, 246-7. PubMed ID: 10312459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcosting method for small-volume injectables.
    Hatoum HT; Witte KW; Biedron GT; Hutchinson RA
    Am J Hosp Pharm; 1986 Feb; 43(2):348-54. PubMed ID: 3953595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considering product features and costs in selecting a system for intermittent i.v. drug delivery.
    Rapp RP
    Am J Hosp Pharm; 1987 Nov; 44(11):2533-8. PubMed ID: 3318417
    [No Abstract]   [Full Text] [Related]  

  • 20. Decision analysis applied to the purchase of frozen premixed intravenous admixtures.
    Witte KW; Eck TA; Vogel DP
    Am J Hosp Pharm; 1985 Apr; 42(4):835-9. PubMed ID: 4014235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.